Exagen (XGN) director lists 7,500 restricted stock units in Form 3

Rhea-AI Filing Summary

EXAGEN INC. director Chas McKhann has filed an initial ownership report on Form 3. The filing shows he holds 7,500 Restricted Stock Units, reported as directly owned. The entry is classified as a holding, with no buy or sell transactions reported in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McKhann Chas

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--

Holdings After Transaction: Restricted Stock Units — 7,500 shares (Direct)

Footnotes (1)

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McKhann Chas

(Last) (First) (Middle)

5717 VERNON AVENUE S.

(Street)

EDINA MN 55436

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
EXAGEN INC. [ XGN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	7,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jeffrey G. Black, as attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Exagen (XGN) Form 3 filing by Chas McKhann report?

The Form 3 filing reports director Chas McKhann’s initial beneficial ownership in Exagen. It shows he holds 7,500 Restricted Stock Units, reported as a direct holding, and classifies this as a holding entry rather than a new trade.

How many Restricted Stock Units does Chas McKhann report holding in Exagen (XGN)?

Chas McKhann reports holding 7,500 Restricted Stock Units of Exagen. This total is listed as the number of units beneficially owned following the reported entry, indicating his current RSU position as shown in this Form 3 filing.

Does the Exagen (XGN) Form 3 for Chas McKhann show any stock purchases or sales?

The Form 3 shows no reported purchases or sales. It classifies the entry as a holding, with zero buy and sell transactions in the transaction summary, focusing solely on the disclosure of 7,500 Restricted Stock Units owned.

Is Chas McKhann a director or officer of Exagen (XGN) in this Form 3?

The filing identifies Chas McKhann as a director of Exagen and not as an officer. The officer fields are marked as not applicable, while the director box is marked, framing the RSU holding in his capacity as a board member.

How is ownership of the 7,500 Exagen (XGN) RSUs classified in the Form 3?

The 7,500 Restricted Stock Units are classified as directly owned by Chas McKhann. The ownership code is shown as “D” for direct, and there is no indication of indirect ownership through entities or related persons in this filing.